CD4 and endometrial carcinoma: On the contrary, Chang et al. studied the phenotype expression of CD4+CD25+ Treg cells in the tumor-infiltrating lymphocytes of 57 endometrial carcinomas by flow cytometry, and reported a significant positive correlation with tumor grade, stage, and myometrial invasion [49].